| http://www.w3.org/ns/prov#value | - However, a report of vascular neoplasms and other pathologies in mice, rats and monkeys after administration of a function-blocking DLL4 antibody, soluble DLL4 fusion protein or DBZ101 has slowed the development of DLL4 inhibitors.High levels of DLL4 are correlated with resistance to inhibitors of VEGF signalling in some tumour types.
|
